DeepMed Research

MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Kisspeptin Administration in the Adult

Phase 1

Completed

Conditions: Kallmann Syndrome
GnRH Deficiency
Polycystic Ovarian Syndrome
Hyperprolactinemia
Hypogonadotropic Hypogonadism
PCOS

Interventions: Drug: kisspeptin 112-121
Drug: GnRH

First Posted Date: 2009-06-05

Last Posted Date: 2024-07-31

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 256

Registration Number: NCT00914823

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Natural Orifice Translumenal Endoscopic Surgery: Laparoscopic-Assisted Transvaginal Cholecystectomy

Phase 1

Terminated

Conditions: Cholelithiasis

First Posted Date: 2009-05-29

Last Posted Date: 2012-10-30

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 3

Registration Number: NCT00910325

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Intentional Rejection of the Donor Graft Using Recipient Leukocyte Infusion(s) Following Nonmyeloablative Allogeneic Stem Cell Transplant

Phase 1

Terminated

Conditions: Non Hodgkin's Lymphoma
Hodgkin Disease
Multiple Myeloma

Interventions: Radiation: Total body irradiation
Other: Fludarabine and total body irradiation

First Posted Date: 2009-05-29

Last Posted Date: 2018-03-29

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 7

Registration Number: NCT00909948

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Concurrent Electronic Order Entry Variation Reporting Impact on Ordering Behavior

Conditions: Behavior

First Posted Date: 2009-05-25

Last Posted Date: 2009-05-25

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 72

Registration Number: NCT00907816

Locations: 🇺🇸
Mass General Hospital, Boston, Massachusetts, United States

Chantix in Adult Smokers With Attention Deficit Hyperactivity Disorder (ADHD)

Phase 4

Terminated

Conditions: Smoking Cessation
Attention Deficit/Hyperactivity Disorder

Interventions: Drug: Varenicline (Chantix)

First Posted Date: 2009-05-22

Last Posted Date: 2017-10-20

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 2

Registration Number: NCT00907218

Treating Sleep/Wake Cycle Disturbances in Basal Ganglia Disorders With Ramelteon

Not Applicable

Withdrawn

Conditions: Huntington's Disease
Parkinson's Disease
Dementia With Lewy Bodies
Sleep Disorders
Circadian Dysregulation

Interventions: Drug: Ramelteon
Drug: Placebo

First Posted Date: 2009-05-22

Last Posted Date: 2012-11-06

Lead Sponsor: Massachusetts General Hospital

Registration Number: NCT00907595

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17

Conditions: Breast Cancer

First Posted Date: 2009-05-12

Last Posted Date: 2013-07-10

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 957

Registration Number: NCT00897065

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

High Dose Rituximab for Initial Treatment of Indolent B-Cell Lymphomas

Phase 2

Completed

Conditions: B-cell Lymphoma
Indolent B-cell Lymphoma

Interventions: Drug: rituximab

First Posted Date: 2009-05-08

Last Posted Date: 2017-06-09

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 40

Registration Number: NCT00895661

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States

DIVINE: Dialysis Infection and Vitamin D In New England

Not Applicable

Completed

Conditions: End Stage Renal Disease

Interventions: Other: Placebo
Drug: Ergocalciferol

First Posted Date: 2009-05-04

Last Posted Date: 2018-04-20

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 105

Registration Number: NCT00892099

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States

Study of Islet Transplantation in Type 1 Diabetic Kidney Transplant Recipients

Phase 1

Completed

Conditions: Diabetes Mellitus, Type I

Interventions: Biological: Purified Pancreatic Islets
Drug: Etanercept

First Posted Date: 2009-04-27

Last Posted Date: 2017-11-29

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 7

Registration Number: NCT00888628

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy